Concepedia

Xiaoli Ling

XL

Statistics

Publications

2

Citations

40

H-Index

2

Active since

2022

Affiliations

University of South China(Current)

Xiaoli Ling is an author at University of South China specializing in drug delivery, cancer nanotherapy, and hepatocellular carcinoma treatment.

Publications per year

2022–2024

2

Publications

2

Prolonged blood circulation outperforms active targeting for nanocarriers-mediated enhanced hepatocellular carcinoma therapy in vivo

Yueqing Wang, Cong Huang, Peng-Ju Ye et al. · Journal of Controlled Release · 2022 · 30 citations

, , +14

Histidine phosphatase-ferroptosis crosstalk modulation for efficient hepatocellular carcinoma treatment

Xiaoli Ling, Yunxian Li, Jieqiong Wang et al. · Journal of Nanobiotechnology · 2024 · 10 citations · Full text

, , +16

1–2 of 2